- JP-listed companies
- HISAMITSU PHARMACEUTICAL CO.,INC.
HISAMITSU PHARMACEUTICAL CO.,INC.JP:4530
Market cap
¥343.8B
P/E ratio
34.9x
| Feb 28, 2013 | Feb 28, 2014 | Feb 28, 2015 | Feb 29, 2016 | Feb 28, 2017 | Feb 28, 2018 | Feb 28, 2019 | Feb 29, 2020 | Feb 28, 2021 | Feb 28, 2022 | Feb 28, 2023 | Feb 29, 2024 | |
| Profit (loss) before income taxes | 31,991 | 33,727 | 29,416 | 27,922 | 29,984 | 27,694 | 25,673 | 26,155 | 12,197 | 12,956 | 16,113 | 19,186 |
| Depreciation | 6,878 | 6,619 | 6,667 | 7,477 | 6,438 | 6,005 | 5,742 | 4,251 | 4,079 | 4,321 | 4,952 | 5,110 |
| Impairment losses | 1,353 | - | - | - | 2,354 | 1,023 | 138 | 953 | - | - | - | 847 |
| Amortization of goodwill | 715 | 873 | 946 | 1,068 | 930 | - | - | - | - | - | - | 62 |
| Increase (decrease) in retirement benefit liability | - | - | 298 | 275 | 288 | 284 | 227 | 119 | 336 | 231 | 206 | 193 |
| Increase (decrease) in provision for bonuses | 87 | 60 | 149 | -310 | -186 | -13 | -17 | -62 | -182 | -22 | -71 | 468 |
| Increase (decrease) in allowance for doubtful accounts | -2 | 40 | 69 | -41 | 29 | -71 | 64 | 26 | 28 | 34 | -169 | -14 |
| Interest and dividend income | -500 | -562 | -624 | -800 | -967 | -1,217 | -1,563 | -1,954 | -1,406 | -1,058 | -1,873 | -3,684 |
| Interest expenses | 38 | 34 | 34 | 32 | 39 | 32 | 19 | 19 | 10 | 20 | 15 | 18 |
| Foreign exchange losses (gains) | -83 | -23 | -160 | 178 | 5 | 69 | 126 | -40 | 84 | -932 | -1,219 | -780 |
| Share of loss (profit) of entities accounted for using equity method | -6,540 | -8,456 | -6,201 | 11 | -471 | -129 | -619 | -786 | -133 | -569 | -424 | -585 |
| Loss (gain) on sale of investment securities | -1 | -108 | -22 | - | - | -487 | -1,312 | - | -188 | -653 | 47 | -389 |
| Loss (gain) on valuation of investment securities | - | - | 60 | - | - | - | - | 176 | - | - | 210 | - |
| Loss (gain) on disposal of non-current assets | 208 | 291 | -6 | 86 | 58 | 15 | 72 | -45 | -177 | 55 | -319 | 5 |
| Decrease (increase) in trade receivables | -3,068 | 571 | -8,506 | 8,626 | 1,371 | 667 | -5,310 | -9,422 | 8,955 | 2,191 | 780 | -2,082 |
| Decrease (increase) in inventories | -754 | -1,365 | 370 | -605 | -2,262 | 485 | 1,310 | 232 | -4,325 | 3,073 | -1,581 | -1,628 |
| Decrease (increase) in other current assets | 621 | -445 | 394 | -46 | -586 | -41 | -892 | 1,742 | -1,507 | 295 | -65 | -1,047 |
| Increase (decrease) in trade payables | 792 | 896 | 2,840 | -3,868 | 421 | -316 | 649 | 4,944 | -3,812 | -2,196 | 653 | 686 |
| Increase (decrease) in contract liabilities | - | - | - | - | - | - | - | - | - | - | -1,030 | -1,380 |
| Increase (decrease) in other current liabilities | 1,759 | 4,180 | 418 | -189 | -4,677 | 1,795 | -897 | 1,008 | -1,864 | 653 | 1,015 | 3,577 |
| Other, net | 412 | 540 | 185 | 216 | 330 | 412 | 184 | 970 | -701 | -430 | -1,060 | -87 |
| Subtotal | 34,203 | 36,869 | 26,430 | 38,686 | 30,194 | 36,180 | 23,665 | 28,315 | 11,609 | 18,282 | 16,179 | 18,474 |
| Interest and dividends received | 8,162 | 12,360 | 10,711 | 818 | 984 | 1,240 | 1,465 | 2,041 | 1,734 | 1,446 | 1,897 | 3,757 |
| Interest paid | -38 | -35 | -34 | -33 | -39 | -32 | -19 | -19 | -9 | -20 | -15 | -18 |
| Income taxes paid | -9,841 | -13,349 | -13,874 | -8,548 | -11,228 | -6,935 | -9,339 | -2,941 | -7,320 | -505 | -5,333 | -4,017 |
| Payments of retirement benefits for directors (and other officers) | - | - | - | - | - | - | - | - | -724 | -3 | - | -7 |
| Net cash provided by (used in) operating activities | 32,485 | 35,845 | 23,232 | 30,923 | 19,910 | 30,453 | 15,772 | 27,395 | 5,289 | 19,199 | 12,727 | 18,188 |
| Decrease (increase) in time deposits | -134 | -315 | -1,317 | 1,737 | 582 | -300 | -36,218 | -3,128 | -178 | -11,007 | -13,068 | 15,572 |
| Purchase of property, plant and equipment | -4,976 | -4,089 | -4,691 | -5,052 | -3,125 | -3,131 | -3,626 | -3,698 | -3,341 | -3,610 | -7,859 | -12,924 |
| Proceeds from sale of property, plant and equipment | 5 | 6 | 117 | 54 | 54 | 82 | 291 | 74 | 642 | 37 | 1,004 | 186 |
| Purchase of intangible assets | -659 | -119 | -180 | -97 | -74 | -209 | -37 | -28 | -47 | -583 | -49 | -112 |
| Decrease (increase) in short-term investment securities | -967 | -532 | 556 | -1,737 | 909 | 2,072 | -530 | -9,514 | 9,715 | 1,498 | 1,848 | 155 |
| Purchase of investment securities | -1,763 | -1,354 | -3,867 | -806 | -493 | -691 | -353 | -1,615 | -191 | -340 | -5,897 | -15 |
| Proceeds from sale and redemption of investment securities | 3 | 1,045 | 279 | - | 3 | 804 | 1,898 | - | 258 | 931 | 151 | 1,397 |
| Payments for acquisition of businesses | - | - | - | - | - | - | - | - | - | - | - | -6,800 |
| Proceeds from collection of loans receivable | 44 | 14 | 7 | 11 | 7 | 6 | 6 | 6 | 2 | 2 | 2 | 2 |
| Other, net | - | - | - | - | - | - | - | - | - | - | - | 25 |
| Net cash provided by (used in) investing activities | -7,946 | -5,843 | -8,945 | -3,912 | 1,070 | -1,378 | -39,302 | -17,229 | 7,815 | -13,060 | -23,868 | -2,512 |
| Increase (decrease) in short-term borrowings | -211 | 63 | 20 | 45 | -115 | -100 | -100 | -150 | -100 | -40 | - | -4 |
| Repayments of long-term borrowings | -2,803 | -243 | -137 | -370 | -78 | -71 | -71 | -67 | -69 | -77 | -71 | -66 |
| Dividends paid to non-controlling interests | - | - | - | -132 | -50 | -59 | -68 | -54 | -115 | -44 | -61 | -111 |
| Purchase of treasury shares | - | -3 | -1 | -4,178 | -11,153 | -2 | -6,176 | -4,520 | -2 | -8,043 | -7,694 | -9,796 |
| Dividends paid | -6,000 | -5,998 | -6,642 | -7,067 | -6,944 | -6,855 | -6,882 | -6,836 | -6,806 | -6,839 | -6,719 | -6,578 |
| Other, net | -202 | -223 | -194 | -158 | -60 | -64 | -48 | -97 | -94 | -144 | -140 | -133 |
| Net cash provided by (used in) financing activities | -9,288 | -6,476 | -7,036 | -11,616 | -18,402 | -7,153 | -13,347 | -11,726 | -7,187 | -15,189 | -14,687 | -16,691 |
| Effect of exchange rate change on cash and cash equivalents | 1,387 | 3,394 | 3,582 | -67 | -909 | -963 | -908 | -225 | -1,559 | 3,944 | 5,005 | 1,957 |
| Net increase (decrease) in cash and cash equivalents | 16,637 | 26,920 | 10,833 | 15,326 | 1,669 | 20,959 | -37,786 | -1,786 | 4,357 | -5,106 | -20,822 | 941 |